PRECOMBAT: PCI viable for unprotected left main disease

The SYNTAX study, which randomised patients with complex severe coronary disease to either CABG or PCI, found that CABG remains a superior treatment option for the majority of these patients.¬† However, in a substudy of patients who had left main stem (LMS) disease, SYNTAX suggested equipoise between the two treatments. ¬†Since then, the debate about […]

Read More…